Invention Grant
- Patent Title: Methods for treating ocular disease using inhibitors of CSF-1R
-
Application No.: US16341075Application Date: 2017-10-13
-
Publication No.: US10537563B2Publication Date: 2020-01-21
- Inventor: Christopher Adams , Muneto Mogi , Stephen Hedrick Poor , Timothy Michael Ramsey , Henry Wu , Qin Zhang
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agent Asha K. Nadipuram
- International Application: PCT/IB2017/056380 WO 20171013
- International Announcement: WO2018/069893 WO 20180419
- Main IPC: A61K31/4427
- IPC: A61K31/4427 ; A61K31/4439 ; A61P27/02 ; A61K9/00
Abstract:
The present invention provides in one aspect methods for treating ocular diseases by administering pharmaceutical compositions comprising an inhibitor of colony stimulating factor-1 (CSF-1) receptors. In another aspect, the present invention provides pharmaceutical compositions for treating ocular diseases, the compositions comprising at least one inhibitor of CSF-1R. The inhibitor can also be a selective inhibitor of CSF-1R in certain embodiments.
Public/Granted literature
- US20190231765A1 METHODS FOR TREATING OCULAR DISEASE USING INHIBITORS OF CSF-1R Public/Granted day:2019-08-01
Information query
IPC分类:
